Compare TGTX & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGTX | SIRI |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.3B |
| IPO Year | 2008 | 1996 |
| Metric | TGTX | SIRI |
|---|---|---|
| Price | $55.33 | $30.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $49.80 | $28.86 |
| AVG Volume (30 Days) | 2.5M | ★ 4.3M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.03% |
| EPS Growth | ★ 1746.67 | 136.32 |
| EPS | 0.12 | ★ 0.72 |
| Revenue | $2,785,000.00 | ★ $5,425,129,000.00 |
| Revenue This Year | $49.08 | $1.81 |
| Revenue Next Year | $26.69 | $0.67 |
| P/E Ratio | $459.33 | ★ $42.01 |
| Revenue Growth | N/A | ★ 8.13 |
| 52 Week Low | $25.37 | $19.77 |
| 52 Week High | $59.30 | $31.42 |
| Indicator | TGTX | SIRI |
|---|---|---|
| Relative Strength Index (RSI) | 60.43 | 68.09 |
| Support Level | $28.57 | $20.30 |
| Resistance Level | $57.38 | $31.42 |
| Average True Range (ATR) | 2.40 | 0.83 |
| MACD | -0.54 | 0.08 |
| Stochastic Oscillator | 51.47 | 87.34 |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service via a fleet of geostationary satellites it owns and operates and now offers a streaming SiriusXM option. Pandora, which accounts for a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants such as Spotify, Apple Music, and YouTube Music.